Bacteriophage having killing activity specific to Staphylococcus aureus
US8071352B2 · kind B2 · utility
14Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2007 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Nov 29, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/10132
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel bacteriophage, more precisely a novel bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious diseases in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.